Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Assunto principal
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 17(5): 1346-8, 2007 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-17188865

RESUMO

Quaternized chlorpromazine, triflupromazine, and promethazine derivatives were synthesized and examined as antitubercular agents against both actively growing and non-replicating Mycobacterium tuberculosis H37Rv. Impressively, several compounds inhibited non-replicating M. tuberculosis at concentrations equal to or double their MICs against the actively growing strain. All active compounds were non-toxic toward Vero cells (IC50 > 128 microM). N-Allylchlorpromazinium bromide was only weakly antitubercular, but replacing allyl with benzyl or substituted benzyl improved potency. An electron-withdrawing substituent on the phenothiazine ring was also essential. Branching at the carbon chain decreased antitubercular activity. The optimum antitubercular structures possessed N-(4- or 3-chlorobenzyl) substitution on triflupromazine.


Assuntos
Antituberculosos/síntese química , Antituberculosos/farmacologia , Clorpromazina/síntese química , Clorpromazina/farmacologia , Mycobacterium tuberculosis/efeitos dos fármacos , Promazina/síntese química , Promazina/farmacologia , Prometazina/síntese química , Prometazina/farmacologia , Compostos de Amônio Quaternário/síntese química , Compostos de Amônio Quaternário/farmacologia , Relação Estrutura-Atividade , Triflupromazina/síntese química , Triflupromazina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...